Enhancer of Zeste Homolog 1 and 2 Inhibitor-induced Colitis Mimicking Immune Checkpoint Inhibitor-induced Colitis.

Intern MedMar 17, 2026 (epub)

Keisuke Iwata, Kenji Yamazaki, Ryoji Kushima et al.

✦ AI-curated · Sources linked

Case in brief

An 80-year-old woman with relapsed nodal T-follicular helper cell lymphoma developed severe watery diarrhea while receiving valemetostat, an EZH1/2 inhibitor. Colonoscopy showed diffuse mucosal erythema and edema. Biopsy demonstrated lymphoplasmacytic infiltration, crypt abscesses, and apoptotic bodies, with CD3-positive T cells predominating and abundant CD8-positive cells. The findings resembled immune checkpoint inhibitor-induced colitis. Her diarrhea improved after valemetostat was discontinued, without additional treatment.

What made this case unusual

The colitis associated with EZH1/2 inhibitor therapy mimicked immune checkpoint inhibitor-induced colitis clinically and histologically, raising a diagnostic consideration beyond the drug class more commonly linked to this pattern.

Diagnostic / clinical pearl

In a patient receiving an EZH1/2 inhibitor who develops persistent diarrhea, consider drug-associated colitis; endoscopic and histological assessment can help characterize the injury.

Source

Published in Intern Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.